Table 2.
Univariate∗ | Stepwise backward∗† | ||||
---|---|---|---|---|---|
B ± SE | p value | B ± SE | p value | ||
Systemic factors | HbA1c (%) | 0.58 ± 0.36 | 0.112 | ||
Duration of diabetes (years) | 0.07 ± 0.05 | 0.107 | 0.12 ± 0.04 | 0.002 | |
| |||||
OCT findings | Preoperative CST (μm) | 0.00 ± 0.00 | 0.828 | ||
Length of EZ disruption (μm) | 0.01 ± 0.00 | <0.001 | 0.01 ± 0.00 | <0.001 | |
Number of HF | 0.18 ± 0.06 | 0.006 | 0.11 ± 0.06 | 0.059 | |
| |||||
Aqueous humor components | IL-1β level (pg/mL) | −0.04 ± 0.21 | 0.855 | ||
IL-8 level (pg/mL) | 0.02 ± 0.02 | 0.3584 | |||
IL-10 level (pg/mL) | −0.03 ± 0.54 | 0.953 | |||
IL-17 level (pg/mL) | 0.19 ± 0.18 | 0.277 | |||
PlGF level (pg/mL) | 0.04 ± 0.12 | 0.738 | |||
VEGF level (pg/mL) | 0.01 ± 0.01 | 0.032 | 0.01 ± 0.00 | 0.007 |
B: estimated regression coefficient; HbA1c: glycated hemoglobin; OCT: optical coherence tomography; CST: central subfield thickness; EZ: ellipsoid zone; HF: hyperreflective foci; IL: interleukin; PlGF: placental growth factor; VEGF: vascular endothelial growth factor. ∗Adjusted for age, sex, and diabetic retinopathy stage. †Adjusted R2 = 0.439.